Skip to main content
Premium Trial:

Request an Annual Quote

New Product Watch: Aug 17, 2010


Gentel Biosciences recently launched its APiX Disease Profiling Kit. The kit contains a single-capture antibody array and is suitable for profiling hundreds of disease-related proteins across multiple disease states, Gentel said.

The kit combines Gentel's APiX chromogenic detection platform and Clontech's research-validated Antibody 380 array technology to help scientists study tumor-associated antigens, compare proteomic and transcriptomic data, and perform target identification and validation using an alternate readout to current fluorescent offerings, according to the firm.

The kit measures data using the Gentel Proteomics Multi-System and AthenaQuant analysis suite of software.

Randox Laboratories has launched two Metabolic Syndrome Arrays. The first biochip, Metabolic Syndrome Array I, includes analytes associated with metabolic syndrome, including: C-peptide, ferritin, IL-1α, IL-6, insulin, leptin, plasminogen activator inhibitor-I, resistin and tumor necrosis factor α.

Metabolic Syndrome Array II includes adiponectin, C-reactive protein, and cystatin C. The Metabolic Syndrome Arrays are suitable for use on plasma and serum, the company said.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.